Mice were injected intradermally with 2.5ug mRNA(HA)-LNP or PBS at the upper left site of the back. Two weeks later, the same spot was injected with 2.5ug mRNA(eGFP)-LNP-DiI. Two days post injection, the mice were sacrificed and the skin and skin draining lymph nodes (axillary and brachial) were harvested. Single-cell suspensions were stained with fixable viability dye (Thermo Fisher), anti-CD45 (30 F11), CD11b (M1/70), Ly-6G (1A8), CD64 (X54–5/7.1), CD11c (N418) and MHCII (M5/114.15.2), as we previously described [71 (link)]. The antibodies were purchased from BioLegend, BD Biosciences and Tonbo Biosciences.
Free full text: Click here